Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $48.2368 (1.32%) ($47.1869 - $48.3243) on Thu. Oct. 1, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.78% (three month average) | RSI | 35 | Latest Price | $48.2368(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) IBB(47%) VYM(47%) IVE(46%) IWD(45%) | Factors Impacting ABBV price | ABBV will decline at least -0.89% in a week (0% probabilities). VIXM(-21%) TLT(-14%) UUP(-9%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.89% (StdDev 1.78%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
1 - 5 Day Possible Target | $39.98(-17.12%) | Resistance Level | $50.65 | 5 Day Moving Average | $47.35(1.87%) | 10 Day Moving Average | $49.13(-1.82%) | 20 Day Moving Average | $50.65(-4.76%) | To recent high | -22.6% | To recent low | 5% | Market Cap | $85.103b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |